The Private Healthcare Exchanges conference July 16-17 in Chicago will focus on how the Affordable Care Act is changing the way insurers sell health insurance.

The discovery of a counterfeit version of the cancer drug Avastin in the U.S. market is the latest illustration of the global problem of falsified and substandard pharmaceutical products. The Institute of Medicine is holding an information-gathering meeting for a new study of the global implications of counterfeit drugs that will explore topics ranging from drug detection technologies to health and trade dimensions.